Steven H. Nelson
Steven H. Nelson's purchase track record
Steven H. Nelson has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/23/2025 | CVS | $1K | +23.8% | +11.5% | +4.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
Transaction History
| HCAT | ▲ Buy | Grant | 80,691 | $0 | 7/16/2026 | View on chart |
| HCAT | ▲ Buy | Grant | 154,808 | $0 | 5/1/2026 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 2,432 | $176K | 4/1/2026 | View on chart |
| CVS | ▲ Buy | Grant | 22,277 | $1.6M | 3/31/2026 | View on chart |
| CVS | ▲ Buy | Grant | 21,329 | $1.4M | 4/1/2025 | View on chart |
| CVS | ▲ Buy | Open Market | 24 | $1K | 1/23/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Health Catalyst Included in List of Unprofitable Stocks
Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.
Health Catalyst Included in List of Unprofitable Stocks. Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.